Company news
Kodiak Sciences Inc news in 2020
Kodiak Sciences Inc's news releases, calls and decks from 2020, newest first.
Kodiak Sciences Announces Closing of $645.0 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
November 19, 2020
Kodiak Sciences Announces Pricing of $560.9 Million Public Offering of Common Stock
November 16, 2020
Kodiak Sciences Completes Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration
November 15, 2020
Kodiak Sciences Announces Proposed Offering of Common Stock
November 15, 2020
Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting
November 10, 2020
Kodiak Sciences Announces Third Quarter 2020 Financial Results and Recent Business Highlights
November 8, 2020
AbCellera and Kodiak Sciences Enter Second Antibody Discovery Collaboration for Ophthalmology Targets
October 28, 2020
Kodiak Sciences Treats First Patients in Three Phase 3 Studies of KSI-301 - Two Studies in Diabetic Macular Edema and One Study in Macular Edema Due to Retinal Vein Occlusion
October 4, 2020
Kodiak Sciences Announces Second Quarter 2020 Financial Results and Recent Business Highlights
August 9, 2020
Kodiak Sciences to Host R&D Webcast to Review Recent Data from the Ongoing Phase 1b Study of KSI-301 and Highlight KSI-301 Clinical Development Progress
July 15, 2020
Kodiak Sciences Announces Upcoming Presentation of KSI-301 Clinical Study Data at American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting and R&D Webinar
July 6, 2020
Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference
May 10, 2020
Kodiak Sciences Announces First Quarter 2020 Financial Results and Recent Business Highlights
May 10, 2020
Kodiak Sciences to Host First Quarter 2020 Business Highlights Webcast on May 12, 2020
May 7, 2020
Kodiak Sciences Appoints Charles Bancroft to Board of Directors
April 1, 2020
"Kodiak" and "Kodiak Sciences" Trademarks Registered to Kodiak Sciences Inc. for Its Exclusive Use
March 23, 2020
Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
March 15, 2020
Kodiak Sciences Announces Upcoming Presentation of Additional KSI-301 Phase 1b Clinical Study Data at Angiogenesis, Exudation, and Degeneration 2020 Meeting
February 4, 2020
Decks in 2020
- AAO – Retina Subspecialty Day 2020
Conference · 30 slides · Nov 11, 2020
- Angiogenesis, Exudation, and Degeneration 2020
Conference · 26 slides · Feb 8, 2020